228 related articles for article (PubMed ID: 38418394)
1. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Root JL; Desai PN; Ly C; Wang B; Jelloul FZ; Zhou J; Mackay S; Alfayez M; Matthews J; Pierce S; Reville PK; Daver N; Abbas HA
Cancer Res Commun; 2024 Mar; 4(3):671-681. PubMed ID: 38391202
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Desai PN; Wang B; Fonseca A; Borges P; Jelloul FZ; Reville PK; Lee E; Ly C; Basi A; Root J; Baran N; Post SM; Deng Q; Sun H; Harmanci AO; Burks JK; Gomez JA; DiNardo CD; Daver NG; Alatrash G; Konopleva M; Green MR; Antunes DA; Futreal A; Hao D; Abbas HA
Cancer Immunol Res; 2023 Jun; ():OF1-OF18. PubMed ID: 37285177
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Desai PN; Wang B; Fonseca A; Borges P; Jelloul FZ; Reville PK; Lee E; Ly C; Basi A; Root J; Baran N; Post SM; Deng Q; Sun H; Harmanci AO; Burks JK; Gomez JA; DiNardo CD; Daver NG; Alatrash G; Konopleva M; Green MR; Antunes DA; Futreal A; Hao D; Abbas HA
Cancer Immunol Res; 2023 May; ():. PubMed ID: 37163233
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
[TBL] [Abstract][Full Text] [Related]
6. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
[TBL] [Abstract][Full Text] [Related]
7. Immune receptor repertoires in pediatric and adult acute myeloid leukemia.
Zhang J; Hu X; Wang J; Sahu AD; Cohen D; Song L; Ouyang Z; Fan J; Wang B; Fu J; Gu S; Sade-Feldman M; Hacohen N; Li W; Ying X; Li B; Liu XS
Genome Med; 2019 Nov; 11(1):73. PubMed ID: 31771646
[TBL] [Abstract][Full Text] [Related]
8. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Abbas HA; Hao D; Tomczak K; Barrodia P; Im JS; Reville PK; Alaniz Z; Wang W; Wang R; Wang F; Al-Atrash G; Takahashi K; Ning J; Ding M; Beird HC; Mathews JT; Little L; Zhang J; Basu S; Konopleva M; Marques-Piubelli ML; Solis LM; Parra ER; Lu W; Tamegnon A; Garcia-Manero G; Green MR; Sharma P; Allison JP; Kornblau SM; Rai K; Wang L; Daver N; Futreal A
Nat Commun; 2021 Oct; 12(1):6071. PubMed ID: 34663807
[TBL] [Abstract][Full Text] [Related]
9. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia.
Lasry A; Nadorp B; Fornerod M; Nicolet D; Wu H; Walker CJ; Sun Z; Witkowski MT; Tikhonova AN; Guillamot-Ruano M; Cayanan G; Yeaton A; Robbins G; Obeng EA; Tsirigos A; Stone RM; Byrd JC; Pounds S; Carroll WL; Gruber TA; Eisfeld AK; Aifantis I
Nat Cancer; 2023 Jan; 4(1):27-42. PubMed ID: 36581735
[TBL] [Abstract][Full Text] [Related]
10. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
[TBL] [Abstract][Full Text] [Related]
12. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.
Hu X; Cao D; Zhou Z; Wang Z; Zeng J; Hong WX
Cell Oncol (Dordr); 2024 Feb; 47(1):97-112. PubMed ID: 37615858
[TBL] [Abstract][Full Text] [Related]
15. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
16. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract][Full Text] [Related]
17. Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.
Goswami M; Prince G; Biancotto A; Moir S; Kardava L; Santich BH; Cheung F; Kotliarov Y; Chen J; Shi R; Zhou H; Golding H; Manischewitz J; King L; Kunz LM; Noonan K; Borrello IM; Smith BD; Hourigan CS
J Transl Med; 2017 Jul; 15(1):155. PubMed ID: 28693586
[TBL] [Abstract][Full Text] [Related]
18. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.
Saxena K; Herbrich SM; Pemmaraju N; Kadia TM; DiNardo CD; Borthakur G; Pierce SA; Jabbour E; Wang SA; Bueso-Ramos C; Loghavi S; Tang G; Cheung CM; Alexander L; Kornblau S; Andreeff M; Garcia-Manero G; Ravandi F; Konopleva MY; Daver N
Cancer; 2021 Oct; 127(20):3761-3771. PubMed ID: 34171128
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
Daver N; Garcia-Manero G; Basu S; Boddu PC; Alfayez M; Cortes JE; Konopleva M; Ravandi-Kashani F; Jabbour E; Kadia T; Nogueras-Gonzalez GM; Ning J; Pemmaraju N; DiNardo CD; Andreeff M; Pierce SA; Gordon T; Kornblau SM; Flores W; Alhamal Z; Bueso-Ramos C; Jorgensen JL; Patel KP; Blando J; Allison JP; Sharma P; Kantarjian H
Cancer Discov; 2019 Mar; 9(3):370-383. PubMed ID: 30409776
[TBL] [Abstract][Full Text] [Related]
20. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
